Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans

Immunologic Research

Volumn 64, Issue 4, 2016, Pages 1013-1024

  Shu, Chengjie ^a,b   Sun, Lingmei ^c   Zhang, Weiming ^a,b  

^a NANJING NORMAL UNIVERSITY   (China)

^b Nanjing Institute for Comprehensive Utilization of Wild Plant   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Caenorhabditis elegans; Candida albicans; Immunity; Thymol

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; THYMOL; ANTIFUNGAL AGENT; CAENORHABDITIS ELEGANS PROTEIN; EPHRIN RECEPTOR A4; MITOGEN ACTIVATED PROTEIN KINASE P38; PMK-1 PROTEIN, C ELEGANS;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CANDIDIASIS; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SAFETY; DRUG STRUCTURE; GENE; GENE EXPRESSION; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE; NONHUMAN; P38 MAPK SIGNALING PATHWAY; PMK 1 GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEK 1 GENE; SIGNAL TRANSDUCTION; SURVIVAL TIME; YOUNG ADULT; ANIMAL; CELL GROWTH; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUTATION; PHOSPHORYLATION; THYMUS (PLANT);

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CANDIDA ALBICANS; CANDIDIASIS; CELL GROWTH PROCESSES; IMMUNITY, INNATE; INTESTINES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, EPHA4; SIGNAL TRANSDUCTION; THYMOL; THYMUS PLANT;

EID: 84954507799     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-016-8785-y     Document Type: Article

References (34)

1. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–28.
2. Berman J, Sudbery PE. Candida Albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet. 2002;3(12):918–30.
3. Kobayashi SD, Cutler JE. Candida albicans hyphal formation and virulence: is there a clearly defined role. Trends Microbiol. 1998;6(3):92–4.
4. Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev Immunol. 2010;10(1):47–58.
5. Kim DH, Ausubel FM. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans. Curr Opin Immunol. 2005;17(1):4–10.
6. Kurz CL, Ewbank JJ. Caenorhabditis elegans: an emerging genetic model for the study of innate immunity. Nat Rev Genet. 2003;4(5):380–90.
7. Means TK, et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med. 2009;206(3):637–53.
8. Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog. 2007;3(7):e101.
9. Pukkila-Worley R, Mylonakis E. From the outside in and the inside out: antifungal immune responses in Caenorhabditis elegans. Virulence. 2010;1(3):111–2.
10. Pukkila-Worley R, Ausubel FM, Mylonakis E. Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog. 2011;7(6):e1002074.
11. Aballay A, et al. Cranberry extract standardized for proanthocyanidins promotes the immune response of Caenorhabditis elegans to Vibrio cholerae through the p38 MAPK pathway and HSF-1. PLoS ONE. 2014;9(7):e103290.
12. Coleman JJ, et al. Antifungal activity of microbial secondary metabolites. PLoS ONE. 2011;6(9):e25321.
13. Tournu H, Serneels J, Van Dijck P. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets. Curr Drug Targets. 2005;6(8):909–22.
14. Breger J, et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 2007;3(2):e18.
15. Idnurm A, et al. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS ONE. 2009;4(9):e7025.
16. Chang W, et al. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. PLoS ONE. 2012;7(7):e41624.
17. Zhao LX, et al. Effect of tetrandrine against Candida albicans biofilms. PLoS ONE. 2013;8(11):e79671.
18. Coleman JJ, et al. Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol. 2010;5(3):321–32.
19. Falcone PM, et al. Evaluating in vitro antimicrobial activity of thymol toward hygiene-indicating and pathogenic bacteria. J Food Prot. 2007;70(2):425–31.
20. Braga PC, et al. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents. 2008;31(5):472–7.
21. Guo N, et al. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. J Med Microbiol. 2009;58(Pt 8):1074–9.
22. Khan A, et al. Effect of two monoterpene phenols on antioxidant defense system in Candida albicans. Microb Pathog. 2015;80:50–6.
23. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94.
24. Sun L, Liao K, Wang D. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans. PLoS ONE. 2015;10(2):e0117695.
25. Sun LM, et al. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans. J Appl Microbiol. 2015;118(4):826–38.
26. Larsen B, et al. Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast. 2006;23(11):795–802.
27. Sun L, et al. In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother. 2009;53(4):1586–91.
28. He K-W, et al. Regulation of aging by unc-13 and sbt-1 in Caenorhabditis elegans is temperature-dependent. Neurosci Bull. 2009;25(6):335–42.
29. Wang D, Wang Y, Shen L. Confirmation of combinational effects of calcium with other metals in a paper recycling mill effluent on nematode lifespan with toxicity identification evaluation method. J Environ Sci (China). 2010;22(5):731–7.
30. Wang D, Xing X. Pre-treatment with mild UV irradiation suppresses reproductive toxicity induced by subsequent cadmium exposure in nematodes. Ecotoxicol Environ Saf. 2010;73(3):423–9.
31. Wu Q, et al. Association of oxidative stress with the formation of reproductive toxicity from mercury exposure on hermaphrodite nematode Caenorhabditis elegans. Environ Toxicol Pharmacol. 2011;32(2):175–84.
32. Li Y, et al. Transmissions of serotonin, dopamine, and glutamate are required for the formation of neurotoxicity from Al2O3-NPs in nematode Caenorhabditis elegans. Nanotoxicology. 2013;7(5):1004–13.
33. Wang D, Xing X. Pre-treatment with mild metal exposure suppresses the neurotoxicity on locomotion behavior induced by the subsequent severe metal exposure in Caenorhabditis elegans. Environ Toxicol Pharmacol. 2009;28(3):459–64.
34. Wang D, et al. Methods for creating mutations in C. elegans that extend lifespan. Biol Aging. 2013;1048:65–75.